found this on facebook today
As part of our continued commitment to clinical validation and evidence generation, we will be sharing research outcomes of our proprietary medication for autism spectrum disorder at the upcoming United in Compassion (UIC) Medicinal Cannabis Symposium in Brisbane this Friday, 11 August at 4.30 – 6.30pm.At the poster session, we will showcase our research and real-world data trial in ASD and share the treatment goals and responses of three Australian ASD patients: Kai, Zach and Asher.These real-life cases present clinical insights into the prescription of our proprietary medication for Australian children with severe and uncontrolled autism spectrum disorder (ASD) when conventional pharmacotherapy proved ineffective.
Ann: Appendix 4C Cash Flow Report, page-7
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.080(13.3%) |
Mkt cap ! $5.900M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 52.0¢ | $2.514K | 4.409K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 8990 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 800 | 1 |
View Market Depth
| Last trade - 15.50pm 31/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |